By March 25, 2016, NIH will release the new FORMS D packet to accommodate the updated requirements for applications due on or after May 25, 2016. 

The changes in the new FORMS D packet focus on the following areas:

CCTS Abstract Extension.jpg

The deadline to submit an abstract for the CCTS Spring Conference and cooperating conferences has been extended (for most sessions*) to Friday, April 1, 2016. 

florida_5-2015_copy.jpg

When you ask Brett Spear about what he most admires in his wife and colleague, Martha Peterson, a smile instantly appears on his face.

The pair, both professors in the University of Kentucky College of Medicine Department ofMicrobiology, Immunology and Molecular Genetics, has been married for 32 years and has two sons. Yet, because they have different last names, not everyone on campus recognizes their connection. 

OSPA PI Tracking Report Instructions_Page_1.jpg

OSPA recently published instructions allowing PIs to track their own eIAFs.  To access the instructions, follow the link below.

http://www.research.uky.edu/ospa/info/docs/OSPA%20PI%20Tracking%20Report%20Instructions.pdf

 

 

NIH is now requiring grant applicants to validate key reagents to be used in the proposed research, particularly cell lines.  Major journals are also starting to require such validation for publication.  The preferred validation method is STR (short tandem repeat) profiling.  Commercial firms provide this service for fees ranging from $70 to $300, depending on the firm and the precise work being done. 

Dr_ John Patterson Seminar.jpg
The laboratories of University of Kentucky researchers Anika Hartz, Ph.D., and Christopher Norris, Ph.D., published research studying the pathologies of Alzheimer’s disease and traumatic brain injury (TBI), respectively, in the most recent issue of The Journal of Neuroscience. Both Alzheimer’s disease and TBI impair patients’ memory and cognitive abilities, but they have different causes.

Beginning March 25, 2016, the website Grants.NIH.gov will be transformed into a more helpful and usable site. NIH has used input from surveys, reviews and discussion panels to create a more streamlined site with less clutter and more context. The new site will offer a new homepage, an updated forms page and improved details on how to apply.

To access the NIH site, click here.

 

The purpose of the Research Enrichment Program (REP) is to stimulate new research and support existing research and scholarly activities within units (departments, centers, and institutes), thus supporting the university's strategic objective of facilitating interdisciplinary research and collaborative scholarship. The REP funds will be awarded to units according to the percentage distribution indicated in Item #8 on the eIAF.

As a reminder, the University of Kentucky defines an investigator in the Administrative Regulations 7:2 as, “project director or principal investigator/program director, co-investigator, collaborator, senior/key personnel, faculty associate, and any other person, regardless of title or position, who is responsible for the design, conduct, reporting, or proposing of research or other activity that is sponsored by an extramural agency.” Investigators also include “other significant contributors” and “sub-investigators.” All investigators on a sponsored project proposal should be included on t

kyprianouheadshot_0_0.jpg
Dr. Natasha Kyrpianou has been chosen as the 2016 Urology Care Foundation Distinguished Research Scholar Alumna. The award recognizes those in the urologic community who have compiled significant and substantial research and demonstrated academic leadership as well as a commitment to scholarship to advance urology care. Dr.
The University of Kentucky Gill Heart Institute has named Dr. Helen Hobbs and Dr. Barry Coller as recipients of the 2016 Gill Award in recognition of their lifelong achievements in the study of cardiovascular biology and disease. "Both Helen's and Barry's work have changed the standard of cardiovascular clinical care," said Dr. Susan Smyth, director of the Gill Heart Institute.
dutch-lab-photo.jpg

From Zika to Ebola, the emerging viruses of the 21st century pose a threat to populations throughout the world as silent invaders of the human body. While viruses infect most people multiple times a year with varying degrees of severity and symptoms, no two viruses function in exactly the same way.

Clinical trial research is an important component of the academic activities at the University of Kentucky.  The administrative issues related to the financial management of clinical trial research are challenging, but need to be addressed to facilitate efficiency and compliance.  We have engaged Huron Consulting to provide a nationwide perspective on best practices on fiscal management of clinical trial research.  Below is the provisional suggestion for the scope of the project:

All faculty in the College of Medicine (physicians and basic scientists) are required to participate in financial conflict of interest disclosures.  The 2 types are disclosure are listed below:

 University Research Professorship  

 

 The SRAS-generated department-level financial reports have now been posted for January 2016.  These reports are provided monthly and are found in the “Grants Reports” folder on the College’s Finance SharePoint site, to which all chairs/directors and department administrators should have access.  If any chair/director or administrator would like assistance with accessing these reports, or has questions upon reviewing them, please contact

VWR has partnered with a host of scientific suppliers to bring on site service to campus.  To learn more about the services offered, click on the flyer below.

 Grand Opening of the Life Sciences Supply Cneter

Friday, February 19

10:00 - 1:00

Combs Building Atrium

 

rabchevsky-team.jpg.jpeg

At the age of 19, Sasha Rabchevsky was a strong safety on the Hampden-Sydney College football team when a motorcycle accident left him paralyzed from the chest down.

Rabchevsky has transformed that dreadful turn of events into a meaningful career searching for ways to repair spinal cord damage and improve the lives of those living with spinal cord injury (SCI).

"After my accident, I knew I wanted to pursue research to understand what my condition was and if not cure it, figure out and understand why there was no cure," he said.